Intraoperative Dexmedetomidine and Long-term Outcomes in Elderly After Major Surgery
Status:
Active, not recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a 3-year follow-up of patients enrolled in a previous randomized controlled trial
which showed that intraoperative dexmedetomidine reduced delirium in elderly patients after
major non-cardiac surgery. The purpose of this study is to clarify the effects of
intraoperative dexmedetomidine on long-term outcomes of these patients.